nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—endogenous depression	0.846	1	CbGaD
Quinidine barbiturate—KCNK1—brainstem—endogenous depression	0.00492	0.0423	CbGeAlD
Quinidine barbiturate—KCNK1—forebrain—endogenous depression	0.00475	0.0408	CbGeAlD
Quinidine barbiturate—KCNK1—adrenal cortex—endogenous depression	0.0044	0.0378	CbGeAlD
Quinidine barbiturate—KCNK1—cardiovascular system—endogenous depression	0.00401	0.0345	CbGeAlD
Quinidine barbiturate—GRIA2—brainstem—endogenous depression	0.004	0.0344	CbGeAlD
Quinidine barbiturate—GRIA2—forebrain—endogenous depression	0.00386	0.0332	CbGeAlD
Quinidine barbiturate—KCNK1—pituitary gland—endogenous depression	0.00355	0.0306	CbGeAlD
Quinidine barbiturate—KCNK1—adrenal gland—endogenous depression	0.00317	0.0273	CbGeAlD
Quinidine barbiturate—KCNK1—midbrain—endogenous depression	0.00313	0.027	CbGeAlD
Quinidine barbiturate—KCNK1—thyroid gland—endogenous depression	0.00306	0.0264	CbGeAlD
Quinidine barbiturate—Quinine—CYP2D6—endogenous depression	0.00264	0.532	CrCbGaD
Quinidine barbiturate—GABRA2—brainstem—endogenous depression	0.0026	0.0224	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—endogenous depression	0.00258	0.0222	CbGeAlD
Quinidine barbiturate—SCN5A—Interaction between L1 and Ankyrins—ANK3—endogenous depression	0.00257	0.0788	CbGpPWpGaD
Quinidine barbiturate—GRIA2—midbrain—endogenous depression	0.00255	0.022	CbGeAlD
Quinidine barbiturate—GABRA1—brainstem—endogenous depression	0.00251	0.0216	CbGeAlD
Quinidine barbiturate—GABRA2—forebrain—endogenous depression	0.00251	0.0216	CbGeAlD
Quinidine barbiturate—KCNK1—central nervous system—endogenous depression	0.00248	0.0213	CbGeAlD
Quinidine barbiturate—GABRA1—forebrain—endogenous depression	0.00243	0.0209	CbGeAlD
Quinidine barbiturate—KCNK1—cerebellum—endogenous depression	0.00242	0.0209	CbGeAlD
Quinidine barbiturate—CHRM2—forebrain—endogenous depression	0.00241	0.0208	CbGeAlD
Quinidine barbiturate—SCN5A—cardiovascular system—endogenous depression	0.0024	0.0206	CbGeAlD
Quinidine barbiturate—Quinidine—CYP2D6—endogenous depression	0.00232	0.468	CrCbGaD
Quinidine barbiturate—GRIA2—endocrine gland—endogenous depression	0.00224	0.0193	CbGeAlD
Quinidine barbiturate—GRIA2—nervous system—endogenous depression	0.0021	0.018	CbGeAlD
Quinidine barbiturate—CHRM2—cardiovascular system—endogenous depression	0.00204	0.0176	CbGeAlD
Quinidine barbiturate—GRIA2—central nervous system—endogenous depression	0.00202	0.0174	CbGeAlD
Quinidine barbiturate—GRIA2—cerebellum—endogenous depression	0.00197	0.017	CbGeAlD
Quinidine barbiturate—KCNK1—brain—endogenous depression	0.00197	0.0169	CbGeAlD
Quinidine barbiturate—KCNH2—forebrain—endogenous depression	0.00174	0.015	CbGeAlD
Quinidine barbiturate—GABRA2—adrenal gland—endogenous depression	0.00168	0.0144	CbGeAlD
Quinidine barbiturate—GRIA2—brain—endogenous depression	0.0016	0.0138	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—endogenous depression	0.0016	0.0138	CbGeAlD
Quinidine barbiturate—SCN5A—nervous system—endogenous depression	0.00154	0.0132	CbGeAlD
Quinidine barbiturate—SCN5A—central nervous system—endogenous depression	0.00148	0.0127	CbGeAlD
Quinidine barbiturate—KCNH2—cardiovascular system—endogenous depression	0.00147	0.0127	CbGeAlD
Quinidine barbiturate—CHRM2—endocrine gland—endogenous depression	0.0014	0.012	CbGeAlD
Quinidine barbiturate—GABRA2—nervous system—endogenous depression	0.00136	0.0117	CbGeAlD
Quinidine barbiturate—GABRA1—nervous system—endogenous depression	0.00132	0.0113	CbGeAlD
Quinidine barbiturate—GABRA2—central nervous system—endogenous depression	0.00131	0.0113	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—endogenous depression	0.00131	0.0113	CbGeAlD
Quinidine barbiturate—KCNH2—pituitary gland—endogenous depression	0.0013	0.0112	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—endogenous depression	0.00128	0.011	CbGeAlD
Quinidine barbiturate—GABRA1—central nervous system—endogenous depression	0.00127	0.0109	CbGeAlD
Quinidine barbiturate—CHRM2—central nervous system—endogenous depression	0.00126	0.0109	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—endogenous depression	0.00124	0.0107	CbGeAlD
Quinidine barbiturate—SCN5A—brain—endogenous depression	0.00118	0.0101	CbGeAlD
Quinidine barbiturate—KCNH2—adrenal gland—endogenous depression	0.00117	0.01	CbGeAlD
Quinidine barbiturate—KCNH2—midbrain—endogenous depression	0.00115	0.0099	CbGeAlD
Quinidine barbiturate—CYP2D6—brainstem—endogenous depression	0.0011	0.00948	CbGeAlD
Quinidine barbiturate—CYP2D6—forebrain—endogenous depression	0.00106	0.00915	CbGeAlD
Quinidine barbiturate—GABRA2—brain—endogenous depression	0.00104	0.00896	CbGeAlD
Quinidine barbiturate—KCNH2—endocrine gland—endogenous depression	0.00101	0.0087	CbGeAlD
Quinidine barbiturate—GABRA1—brain—endogenous depression	0.00101	0.00866	CbGeAlD
Quinidine barbiturate—CHRM2—brain—endogenous depression	0.001	0.00862	CbGeAlD
Quinidine barbiturate—SCN5A—L1CAM interactions—ANK3—endogenous depression	0.000986	0.0303	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—CACNB2—endogenous depression	0.000951	0.0292	CbGpPWpGaD
Quinidine barbiturate—KCNH2—nervous system—endogenous depression	0.000946	0.00814	CbGeAlD
Quinidine barbiturate—KCNH2—central nervous system—endogenous depression	0.000911	0.00784	CbGeAlD
Quinidine barbiturate—KCNH2—cerebellum—endogenous depression	0.00089	0.00766	CbGeAlD
Quinidine barbiturate—KCNH2—brain—endogenous depression	0.000723	0.00622	CbGeAlD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR1A—endogenous depression	0.000697	0.0214	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR2C—endogenous depression	0.000673	0.0207	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000622	0.0191	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—endocrine gland—endogenous depression	0.000616	0.00531	CbGeAlD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000603	0.0185	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR7—endogenous depression	0.00059	0.0181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR1A—endogenous depression	0.000586	0.018	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—nervous system—endogenous depression	0.000577	0.00497	CbGeAlD
Quinidine barbiturate—KCNK1—Neuronal System—COMT—endogenous depression	0.000576	0.0177	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—MAOA—endogenous depression	0.000572	0.0176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR2C—endogenous depression	0.000566	0.0174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—central nervous system—endogenous depression	0.000555	0.00478	CbGeAlD
Quinidine barbiturate—CYP2D6—cerebellum—endogenous depression	0.000543	0.00467	CbGeAlD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR7—endogenous depression	0.000496	0.0152	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000471	0.0145	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000457	0.014	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—brain—endogenous depression	0.000441	0.0038	CbGeAlD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000424	0.013	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR2A—endogenous depression	0.000413	0.0127	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00041	0.0126	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00039	0.012	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000378	0.0116	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000377	0.0116	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000377	0.0116	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ANK3—endogenous depression	0.000373	0.0114	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000365	0.0112	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000365	0.0112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000347	0.0107	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000339	0.0104	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CACNB2—endogenous depression	0.000325	0.00997	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000321	0.00984	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—BDNF—endogenous depression	0.00032	0.00982	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.00031	0.00953	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000298	0.00916	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CACNB2—endogenous depression	0.000287	0.0088	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000283	0.0087	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—WASF2—endogenous depression	0.000283	0.00868	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000275	0.00843	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000273	0.00839	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—WASF1—endogenous depression	0.000271	0.00832	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ANK3—endogenous depression	0.000266	0.00816	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000265	0.00813	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNB2—endogenous depression	0.000263	0.00806	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—HTR7—endogenous depression	0.000262	0.00804	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000261	0.00801	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000257	0.00789	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—COMT—endogenous depression	0.000257	0.00788	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000255	0.00782	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000254	0.00781	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000253	0.00777	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000248	0.00762	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000248	0.00762	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000243	0.00746	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000242	0.00741	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNA1C—endogenous depression	0.00024	0.00737	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000234	0.00719	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000231	0.00709	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—endogenous depression	0.000231	0.00708	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CACNB2—endogenous depression	0.000229	0.00702	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000224	0.00687	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000201	0.00617	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—COMT—endogenous depression	0.000197	0.00604	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAOA—endogenous depression	0.000195	0.00599	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CACNB2—endogenous depression	0.000195	0.00598	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000194	0.00596	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000194	0.00596	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNB2—endogenous depression	0.000187	0.00575	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000187	0.00573	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—HTR2A—endogenous depression	0.000183	0.00563	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—COMT—endogenous depression	0.000181	0.00555	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00018	0.00553	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAOA—endogenous depression	0.00018	0.00551	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—COMT—endogenous depression	0.000174	0.00533	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAOA—endogenous depression	0.000173	0.0053	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000172	0.00528	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNA1C—endogenous depression	0.000171	0.00526	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000159	0.00488	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—COMT—endogenous depression	0.000154	0.00473	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000154	0.00472	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000153	0.0047	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000152	0.00467	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000146	0.00449	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—HTR1A—endogenous depression	0.000145	0.00445	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000141	0.00433	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—COMT—endogenous depression	0.000139	0.00425	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAOA—endogenous depression	0.000138	0.00422	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000135	0.00413	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000134	0.00413	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00013	0.00399	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000125	0.00382	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000123	0.00379	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00012	0.00367	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000119	0.00366	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—COMT—endogenous depression	0.000118	0.00363	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAOA—endogenous depression	0.000117	0.0036	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000115	0.00354	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000114	0.00349	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000111	0.00342	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADM—endogenous depression	0.000109	0.00334	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.0001	0.00307	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	9.75e-05	0.00299	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CRH—endogenous depression	9.12e-05	0.0028	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—OXT—endogenous depression	9.12e-05	0.0028	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR1A—endogenous depression	8.77e-05	0.00269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2C—endogenous depression	8.47e-05	0.0026	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—COMT—endogenous depression	8.22e-05	0.00252	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOA—endogenous depression	8.16e-05	0.00251	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	8.11e-05	0.00249	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.97e-05	0.00245	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR7—endogenous depression	7.42e-05	0.00228	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—endogenous depression	6.86e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.83e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADM—endogenous depression	6.15e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADM—endogenous depression	5.58e-05	0.00171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	5.45e-05	0.00167	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—endogenous depression	5.31e-05	0.00163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—endogenous depression	5.2e-05	0.0016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CRH—endogenous depression	5.15e-05	0.00158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—OXT—endogenous depression	5.15e-05	0.00158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR1A—endogenous depression	4.96e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2C—endogenous depression	4.79e-05	0.00147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CRH—endogenous depression	4.68e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—OXT—endogenous depression	4.68e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR1A—endogenous depression	4.5e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2C—endogenous depression	4.35e-05	0.00133	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR7—endogenous depression	4.19e-05	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—endogenous depression	4.15e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR7—endogenous depression	3.81e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WASF2—endogenous depression	3.61e-05	0.00111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WASF1—endogenous depression	3.46e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADM—endogenous depression	3.3e-05	0.00101	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPH1—endogenous depression	3.06e-05	0.00094	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—endogenous depression	2.94e-05	0.000902	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CRH—endogenous depression	2.76e-05	0.000848	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—OXT—endogenous depression	2.76e-05	0.000848	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—endogenous depression	2.67e-05	0.000819	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR1A—endogenous depression	2.66e-05	0.000816	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2C—endogenous depression	2.57e-05	0.000788	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—endogenous depression	2.35e-05	0.00072	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPH2—endogenous depression	2.32e-05	0.000712	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNB2—endogenous depression	2.32e-05	0.000712	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DPYD—endogenous depression	2.28e-05	0.000701	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR7—endogenous depression	2.25e-05	0.000691	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—endogenous depression	2.13e-05	0.000654	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.12e-05	0.000651	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—endogenous depression	1.58e-05	0.000484	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—endogenous depression	1.41e-05	0.000431	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOA—endogenous depression	1.4e-05	0.000428	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—endogenous depression	1.26e-05	0.000386	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—endogenous depression	9.09e-06	0.000279	CbGpPWpGaD
